These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15341254)

  • 1. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
    Kuzmanov B
    Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endometrial ablation versus hysterectomy in women treated with tamoxifen].
    Capuano I; Caporale A; Vagnetti P; Di Domenico A; Felicetti M; Torella M; Borrelli AL
    Minerva Ginecol; 2007 Oct; 59(5):499-504. PubMed ID: 17912176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of tamoxifen of endometrium].
    Bai P; Sun J; Zhang K
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):226-8. PubMed ID: 11783367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.
    Gibson LE; Barakat RR; Venkatraman ES; Hoskins WJ
    Cancer J Sci Am; 1996; 2(1):35-8. PubMed ID: 9166496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
    López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
    Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
    Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
    Reslová T; Tosner J; Vávrová I; Resl M
    Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
    Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.